EU Drug Applications Will Need Pharmacovigilance Plans In 2005
Executive Summary
Pharmaceutical drug marketing applications to the European Medicines Agency will require a pharmacovigilance plan beginning in November 2005
You may also be interested in...
European Pharmacovigilance Draft Guidance May Be Released In Summer
A European Medicines Agency draft guideline on "monitoring and inspection of compliance with pharmacovigilance obligations" is under review in preparation for a public consultation
European Pharmacovigilance Draft Guidance May Be Released In Summer
A European Medicines Agency draft guideline on "monitoring and inspection of compliance with pharmacovigilance obligations" is under review in preparation for a public consultation
FDA’s Risk Management Guidance To Be Harmonized With Europe, Japan
Risk management and risk assessment collaboration between the U.S., Europe and Japan will be one of the topics discussed at the International Conference on Harmonization in Brussels, Belgium from May 9-12